Positron emission tomography (PET) myocardial perfusion imaging in concert with tracer-
kinetic modeling affords the assessment of regional myocardial blood flow (MBF) of the left …

PET myocardial perfusion imaging (MPI) is increasingly being used for noninvasive
detection and evaluation of coronary artery disease. However, the widespread use of PET …

The continued success of nuclear cardiology demands ongoing re-evaluation of imaging
practices to optimize patient care. The first element of this process is to accurately define …

Absolute quantitation of myocardial blood flow (MBF) by PET is an established method of
analyzing coronary artery disease (CAD) but subject to the various shortcomings of …

Persistent inflammation following myocardial infarction (MI) precipitates adverse outcome
including acute ventricular rupture and chronic heart failure. Molecular imaging allows …

Nuclear cardiology has experienced exponential growth within the past four decades with
converging capacity to diagnose and influence management of a variety of cardiovascular …

18F-galacto-RGD (18F-RGD) is a PET tracer binding to αvβ3 integrin receptors that are
upregulated after myocardial infarction (MI) as part of the healing process. We studied …

The novel PET flow tracer flurpiridaz F 18 shows high myocardial extraction and slow
washout. flurpiridaz F 18 PET data analysis with tracer kinetic modeling provides accurate …

The heart failure epidemic continues to rise with coronary artery disease as one of its main
causes. Novel concepts for risk stratification to guide the referring cardiologist towards …

Positron emission tomography (PET) is increasingly being applied in the evaluation of
myocardial perfusion. Cardiac PET can be performed with an increasing variety of cyclotron …